Manager × security

TOBAM UTHR holdings history

Who else holds this security? →

UNITED THERAPEUTICS CORP · CUSIP 91307C102 · CIK 1527488

Some filings reported values in thousands; those figures were scaled ×1000 to dollars.
This is the oldest quarter open without an account, so changes against the quarter before it are withheld. Sign in to see them.
Citable facts

As of 2026-06-30, TOBAM reported 10.88K UTHR (shares), valued at $5.89M, or 1.43% of its reported non-derivative portfolio. Filed 2026-07-31.

Verify history & sources →
Portfolio weight and quantity history
Reported portfolio weight
1.43%
Shares
10.88K
10,875
Reported value
$5.89M
USD

Shares increased 21.99%; reported value increased 11.46%, and weight changed +0.05 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.

Left: % · Right: Shares · Independently scaled axes

Exact data and methodology

Axes scale independently; a crossing does not mean equal values. Weight uses each quarter's total reported non-derivative value. Same CUSIP; missing quarters are gaps, not zero. Revised history may include later disclosures.

QuarterWeightQuantitySource
Q2 20261.43%10,875SEC filing ↗Filed Jul 31, 2026
Q1 20261.38%8,915SEC filing ↗Filed May 12, 2026
Q4 20251.18%9,857SEC filing ↗Filed Mar 2, 2026
Q3 20251.16%7,646SEC filing ↗Filed Nov 7, 2025
Q2 20250.30%2,693SEC filing ↗Filed Aug 8, 2025
Q1 20250.84%6,388SEC filing ↗Filed Apr 16, 2025
Q4 20241.96%18,222SEC filing ↗Filed Jan 28, 2025
Q3 20242.48%37,941SEC filing ↗Filed Oct 9, 2024
Q2 20242.81%56,258SEC filing ↗Filed Jul 29, 2024Amended
Q1 20242.24%108,647SEC filing ↗Filed May 2, 2024
Q4 20232.19%113,757SEC filing ↗Filed Jan 26, 2024
Q3 20232.64%145,420SEC filing ↗Filed Oct 31, 2023

History & evidence by quarter

QuarterWeightQuantityValueChange explainedSource
Q3 20232.64%145,420$32.85MThe prior quarter is outside the free window. Sign in for the comparison.SEC filing ↗
Filed Oct 31, 2023
Q4 20232.19%113,757$25.01MShares decreased 21.77%; reported value decreased 23.84%, and weight changed -0.45 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed Jan 26, 2024
Q1 20242.24%108,647$24.96MShares decreased 4.49%; reported value decreased 0.22%, and weight changed +0.05 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed May 2, 2024
Q2 20242.81%56,258$17.92MShares decreased 48.22%; reported value decreased 28.20%, and weight changed +0.57 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed Jul 29, 2024
Q3 20242.48%37,941$13.60MShares decreased 32.56%; reported value decreased 24.13%, and weight changed -0.33 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed Oct 9, 2024
Q4 20241.96%18,222$6.43MShares decreased 51.97%; reported value decreased 52.71%, and weight changed -0.52 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed Jan 28, 2025
Q1 20250.84%6,388$1.97MShares decreased 64.94%; reported value decreased 69.37%, and weight changed -1.12 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed Apr 16, 2025
Q2 20250.30%2,693$774.00KShares decreased 57.84%; reported value decreased 60.69%, and weight changed -0.54 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed Aug 8, 2025
Q3 20251.16%7,646$3.21MShares increased 183.92%; reported value increased 314.08%, and weight changed +0.86 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed Nov 7, 2025
Q4 20251.18%9,857$4.80MShares increased 28.92%; reported value increased 49.86%, and weight changed +0.02 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed Mar 2, 2026
Q1 20261.38%8,915$5.29MShares decreased 9.56%; reported value increased 10.06%, and weight changed +0.20 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed May 12, 2026
Q2 20261.43%10,875$5.89MShares increased 21.99%; reported value increased 11.46%, and weight changed +0.05 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed Jul 31, 2026
TOBAM · UNITED THERAPEUTICS CORP

Take these holdings further.

This page includes 12 of 12 reported holdings. Sign in to look up the full history beyond 3 years, use advanced screening & filtering, download CSV, and get the complete set through the Akkru API.

  • Download CSV
  • Earlier quarters
  • Advanced screening & filtering
  • API & AI access
Already have an account?

+ New accounts get free API credits to explore data beyond ownership filings.

For AI agents & developers

The initial HTML of this page carries its exact data as script#research-data (JSON): values, units, scope, preview limits and SEC sources. Read it directly, no script or API key needed; script#research-access says what needs an account.

Without an account: the last 3 years, with the row caps stated on the page. A free account opens all history on file on these pages and the CSV of what a page shows. Rows beyond the caps and bulk retrieval go through the authenticated API / MCP.

MCP  https://api.akkrudata.ai/mcp

get_institutional_portfolio
{"cik":"1527488","quarter":"2026Q2","cusip":"91307C102"}

get_institutional_manager_history
{"cik":"1527488","page_size":100}

Connect to MCP with OAuth and follow the returned pagination. Credits and usage limits depend on the account.

MCP endpoint
https://api.akkrudata.ai/mcp
API / MCP documentation
/documents
llms.txt
/llms.txt
Sources, coverage & how to read this data

Figures are as reported to the SEC and merged with later amendments where Akkru could match them. Preview limits apply to what is listed, not to the totals, which come from the complete reported data. Nothing is zero-filled: a missing quarter or month is shown as missing.

13F reports quarter-end long positions in securities traded on US exchanges, filed by managers holding at least $100 million of such securities; it is not the manager's full portfolio, not assets under management, and value changes are not returns. Weights use the reported total value as denominator. Option rows show notional value, not premium or net exposure. Amendments are merged into the quarter when Akkru could match them.